AbbVie (Brazil) Today

ABBV34 Stock  BRL 67.71  0.22  0.33%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
AbbVie is trading at 67.71 as of the 30th of November 2024, a 0.33% up since the beginning of the trading day. The stock's open price was 67.49. AbbVie has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for AbbVie Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. The company has 28.3 B outstanding shares. More on AbbVie Inc

Moving against AbbVie Stock

  0.52PETR3 Petrleo BrasileiroPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

AbbVie Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AbbVie's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AbbVie or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman of the Board, CEORichard Gonzalez
Business ConcentrationDrug Manufacturers - Major, Healthcare (View all Sectors)
AbbVie Inc (ABBV34) is traded on Sao Paulo Exchange in Brazil and employs 26 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.42 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AbbVie's market, we take the total number of its shares issued and multiply it by AbbVie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AbbVie Inc operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 28.3 B outstanding shares. AbbVie Inc has accumulated about 5.23 B in cash with 13.8 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.54.
Check AbbVie Probability Of Bankruptcy

AbbVie Inc Risk Profiles

Although AbbVie's alpha and beta are two of the key measurements used to evaluate AbbVie's performance over the market, the standard measures of volatility play an important role as well.

AbbVie Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in AbbVie without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Analyzer Now

   

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
All  Next Launch Module

Additional Information and Resources on Investing in AbbVie Stock

When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.